Xeris Biopharma Holdings (XERS) Change in Inventory (2020 - 2026)

Xeris Biopharma Holdings' Change in Inventory history runs 7 years deep, the most recent figure standing at -$851000.0 for Q1 2026.

• Quarterly Change in Inventory fell 123.53% year-over-year to -$851000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (up 47.19% YoY) and the FY2025 annual result came in at $19.3 million, up 119.61% from the prior year.
• Change in Inventory was -$851000.0 for Q1 2026 at Xeris Biopharma Holdings, down from $4.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $7.6 million in Q2 2025 and bottomed at -$851000.0 in Q1 2026.
• A 5-year average of $2.9 million and a median of $2.3 million in 2024 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory jumped 4922.3% — and 2026, when it plunged 123.53%.
• Xeris Biopharma Holdings' Change in Inventory stood at $5.5 million in 2022, then sank by 74.55% to $1.4 million in 2023, then jumped by 123.91% to $3.1 million in 2024, then rose by 27.86% to $4.0 million in 2025, then sank by 121.22% to -$851000.0 in 2026.
• Business Quant data shows XERS's Change in Inventory at -$851000.0 in Q1 2026, $4.0 million in Q4 2025, and $4.1 million in Q3 2025.